$NUVB

$4.76▲ -0.2% YTD

5 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

NUVB ▼ -0.2% - Nuvation Bio Inc.

CP $4.76▲ -0.2%Nov 2, 2026 · ThinkSabio Blog

$NUVB - Nuvation Bio to Present Additional Updated Phase 2 Results at 2026 Society for Neuro-Oncology Annual Meeting…

News

NUVB ▲ +1.5% - Nuvation Bio Inc.

CP $4.85▲ +1.5%Oct 21, 2026 · ThinkSabio Blog

$NUVB - Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026…

News

NUVB ▲ +4.2% - Nuvation Bio Inc.

CP $6.00▲ +4.2%Sep 17, 2026 · ThinkSabio Blog

$NUVB - Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI…

News

NUVB ▼ -0.5% - Nuvation Bio Inc.

CP $5.90▲ -0.5%Sep 15, 2026 · ThinkSabio Blog

$NUVB - Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in A…

News

NUVB ▲ +3.7% - Nuvation Bio Inc.

CP $6.93▲ +3.7%Sep 2, 2026 · ThinkSabio Blog

$NUVB - Nuvation Bio to Participate in Upcoming Investor Conferences…